About Surface Logix
Surface Logix is a Healthcare company based in Boston (United States) founded in 1999, and was acquired by Nano Terra in April 2011. Small molecule therapeutics for metabolic and cardiovascular disorders were developed. Surface Logix has raised $23.9 million across 2 funding rounds from investors including Arch Venture Partners, Nano Terra and Venrock. Its focus areas include Diversified Pharmaceuticals.
Company details
Surface Logix was founded in 1999 in Boston, United States, focusing on biotechnology for metabolic and cardiovascular disorders. Small molecule therapeutics were developed using a proprietary platform that enabled new chemical entities for dynamic pharmacologic responses in human microenvironments. Operations centered on advancing these entities toward clinical applications. The company was acquired.
- Headquarters Boston, United States
- Stage Acquired
- SectorsHealthcare
- Website surfacelogix.com
- Social LinkedIn
- Acquired by Nano Terra (Apr 2011)
- Total Equity Funding$23.9M (USD)
in 2 rounds
- Latest Funding Round$4M (USD), Series D
Jul 2010
- InvestorsArch Venture Partners
& 5 more
- Acquired byNano Terra
(Apr 2011)
Funding Insights of Surface Logix
Surface Logix has successfully raised a total of $23.9M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $4 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23.9M
- Total Rounds 2
- Last Round Series D — $4M
- First Round $19.9M
(Mar 2007)
- Investors Count 5
All 2 funding rounds of Surface Logix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2010 | $4M | Series D | – | – | – |
| Mar 2007 | $19.9M | Series D | – | – |
6 investors in total: 6 institutional.
Investors in Surface Logix
Surface Logix has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Arch Venture Partners, Nano Terra and Venrock.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on tech sectors | venrock.com | Palo Alto, United States | ||
Late-stage life sciences investments are managed via VC and PE. | hbmpartners.com | Zug, Switzerland | ||
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Corporate-backed venture capital firm focused on consumer tech and multiple sectors | unileverventures.com | London, United Kingdom | ||
| cwventures | ||||
Provides coating products for multiple industries | 2005 | nanoterra.com | Cambridge, United States |
Investor details for Surface Logix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Surface Logix
4 dated milestones of Surface Logix across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Surface Logix is founded.
- Funding First funding round of $19.9M.
- Funding Latest funding round, Series D, of $4.0M.
- Exit Acquired by Nano Terra.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Surface Logix (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Surface Logix
Complete news archive for Surface Logix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surface Logix
Surface Logix was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Surface Logix is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Surface Logix is a funded company, having raised a total of $23.9M across 2 funding rounds to date. The company's 1st funding round was a Series D of $19.9M, raised on Mar 2007.
Surface Logix was founded in 1999 in Boston, United States, focusing on biotechnology for metabolic and cardiovascular disorders. Small molecule therapeutics were developed using a proprietary platform that enabled new chemical entities for dynamic pharmacologic responses in human microenvironments. Operations centered on advancing these entities toward clinical applications. The company was acquired.
Surface Logix has 6 investors. Key investors include Arch Venture Partners, Nano Terra, Venrock, HBM Partners, and Unilever Ventures.
Yes. Surface Logix was acquired by Nano Terra in April 2011.